pioglitazone has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joubert, M | 1 |
| Jagu, B | 1 |
| Montaigne, D | 1 |
| Marechal, X | 1 |
| Tesse, A | 1 |
| Ayer, A | 1 |
| Dollet, L | 1 |
| Le May, C | 1 |
| Toumaniantz, G | 1 |
| Manrique, A | 1 |
| Charpentier, F | 1 |
| Staels, B | 1 |
| Magré, J | 1 |
| Cariou, B | 1 |
| Prieur, X | 1 |
1 other study available for pioglitazone and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Type | 2017 |